A Review on the Development of Semisynthetic Phytochemicals in theDiscovery of Anticancer Drugs

Cancer is a serious public health problem worldwide, and research into the development of new targeted cancer drugs is continuing intensively. A wide variety of approaches have been developed, ranging from traditional cytotoxic agents to modern targeted therapies, antibody-drug conjugates, immunotherapies, and advanced drug delivery systems, etc. The integration of omics strategies, bioinformatics, network pharmacology, molecular docking, molecular dynamics simulation, and artificial intelligence techniques into the process has accelerated the development of modern cancer treatments. While the search for different cancer treatment methods and anticancer drugs continues intensively, semi-synthetic drug designs still attract attention. As most targeted anticancer drugs are insufficient in clinical treatment, natural products and their derivatives are important in new multi-targeted anticancer drug research. Alongside traditional plant-derived anticancer agents, cardamonin, harmin, podophyllotoxin, β-carboline, magnolol, α-onocerin, boehmeriasin A, parthenolide, celastrol, pinosembrin, furochromone, curcumin, diosgenin, betulinic acid, ursolic acid, honokiol, goniodiol, scopoletin, caffeic acid, and pinocembrin derivatives have attracted interest due to their enhanced efficacy and selectivity relative to their natural analogs. These phytochemicals or their derivatives offer new strategies and have the potential to reduce the side effects of traditional treatments and overcome drug resistance. This review aims to discuss recent semisynthetic advancements in natural product research for anticancer drug development. It demonstrates that several semisynthetic anticancer candidates with enhanced selective anticancer effects compared to natural precursors have been developed, and that problems such as low bioactivity, poor solubility, or selectivity issues can be effectively resolved through the rational design of the chemical structures of their natural analogs.

Authors

Institutions

Publication Details

Journal
Current Topics in Medicinal Chemistry
Published
2026-04-10
DOI
https://doi.org/10.2174/0115680266467530260405204054
Primary Topic
Magnolia and Illicium research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Review on the Development of Semisynthetic Phytochemicals in theDiscovery of Anticancer Drugs

Cem Yamalı, Fatma Zehra Alkac
Current Topics in Medicinal Chemistry
Magnolia and Illicium research
article

A Review on the Development of Semisynthetic Phytochemicals in theDiscovery of Anticancer Drugs

Cem Yamalı, Fatma Zehra Alkac
article en

Abstract

Cancer is a serious public health problem worldwide, and research into the development of new targeted cancer drugs is continuing intensively. A wide variety of approaches have been developed, ranging from traditional cytotoxic agents to modern targeted therapies, antibody-drug conjugates, immunotherapies, and advanced drug delivery systems, etc. The integration of omics strategies, bioinformatics, network pharmacology, molecular docking, molecular dynamics simulation, and artificial intelligence techniques into the process has accelerated the development of modern cancer treatments. While the search for different cancer treatment methods and anticancer drugs continues intensively, semi-synthetic drug designs still attract attention. As most targeted anticancer drugs are insufficient in clinical treatment, natural products and their derivatives are important in new multi-targeted anticancer drug research. Alongside traditional plant-derived anticancer agents, cardamonin, harmin, podophyllotoxin, β-carboline, magnolol, α-onocerin, boehmeriasin A, parthenolide, celastrol, pinosembrin, furochromone, curcumin, diosgenin, betulinic acid, ursolic acid, honokiol, goniodiol, scopoletin, caffeic acid, and pinocembrin derivatives have attracted interest due to their enhanced efficacy and selectivity relative to their natural analogs. These phytochemicals or their derivatives offer new strategies and have the potential to reduce the side effects of traditional treatments and overcome drug resistance. This review aims to discuss recent semisynthetic advancements in natural product research for anticancer drug development. It demonstrates that several semisynthetic anticancer candidates with enhanced selective anticancer effects compared to natural precursors have been developed, and that problems such as low bioactivity, poor solubility, or selectivity issues can be effectively resolved through the rational design of the chemical structures of their natural analogs.

Current Topics in Medicinal ChemistryVol. 26
Cukurova University (TR)
No poverty
Openalex Percentile: Top 19%
Magnolia and Illicium research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.